Opthea (OPT) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free OPT Stock Alerts $3.58 -0.03 (-0.83%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 10:40 AM | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Oculis Holding (OCS)May 9, 2024 | msn.comThese 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says OppenheimerMay 8, 2024 | markets.businessinsider.comOptiva Awarded ISO 27001 Certification Demonstrating Commitment to CybersecurityMay 8, 2024 | americanbankingnews.comContrasting Fusion Pharmaceuticals (NASDAQ:FUSN) & Opthea (NASDAQ:OPT)May 1, 2024 | finance.yahoo.comOpthea Announces Upcoming Presentations at the Retina World Congress 2024May 1, 2024 | globenewswire.comOpthea Announces Upcoming Presentations at the Retina World Congress 2024April 28, 2024 | msn.comDr Boreham’s Crucible: In rare Phase 3 air, can Opthea now see its way clear to a $15bn market?April 25, 2024 | globenewswire.comOpthea to Present at the OIS Retina Innovation Summit at ARVOApril 12, 2024 | marketbeat.comLeerink Partnrs Research Analysts Decrease Earnings Estimates for Opthea Limited (NASDAQ:OPT)Opthea Limited (NASDAQ:OPT - Free Report) - Investment analysts at Leerink Partnrs reduced their FY2024 EPS estimates for shares of Opthea in a note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst M. Goodman now anticipates that the company will earn ($2.15) per share for the yApril 8, 2024 | globenewswire.comOpthea Appoints John Han, PharmD, as VP Medical AffairsApril 5, 2024 | nasdaq.comOpthea Limited American Depositary Shares (OPT)April 4, 2024 | globenewswire.comOpthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare ConferenceApril 3, 2024 | msn.comWhy A2 Milk, Lindsay Australia, Meridian Energy, and Opthea shares are falling todayApril 3, 2024 | globenewswire.comOpthea Appoints Sujal Shah to the Board of DirectorsApril 3, 2024 | investorplace.com7 Growth Stocks to Buy to Outperform the Nasdaq IndexMarch 19, 2024 | globenewswire.comOpthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024March 14, 2024 | marketbeat.comShort Interest in Opthea Limited (NASDAQ:OPT) Decreases By 21.1%Opthea Limited (NASDAQ:OPT - Get Free Report) saw a large decline in short interest in the month of February. As of February 29th, there was short interest totalling 124,100 shares, a decline of 21.1% from the February 14th total of 157,200 shares. Based on an average daily trading volume, of 37,000 shares, the days-to-cover ratio is currently 3.4 days.March 6, 2024 | msn.comEnd in sight as Opthea looks to be key player in US$10 billion wet AMD marketMarch 5, 2024 | globenewswire.comOpthea to Participate in the Leerink Partners Global Biopharma ConferenceFebruary 28, 2024 | globenewswire.comOpthea Reports Half-Year Financial Results and Business UpdatesFebruary 22, 2024 | au.finance.yahoo.comOpthea Limited (OPT)February 20, 2024 | finanznachrichten.deOpthea Limited: Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical AdvisorFebruary 19, 2024 | globenewswire.comOpthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical AdvisorFebruary 17, 2024 | marketbeat.comOpthea Limited (NASDAQ:OPT) Short Interest Up 8.2% in JanuaryOpthea Limited (NASDAQ:OPT - Get Free Report) was the target of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 124,400 shares, an increase of 8.2% from the January 15th total of 115,000 shares. Based on an average daily volume of 30,900 shares, the short-interest ratio is currently 4.0 days.February 14, 2024 | finanznachrichten.deOpthea Limited: Opthea Completes Enrollment in First Pivotal Trial with SoziniberceptFebruary 14, 2024 | finance.yahoo.comOpthea Completes Enrollment in First Pivotal Trial with SoziniberceptFebruary 14, 2024 | globenewswire.comOpthea Completes Enrollment in First Pivotal Trial with SoziniberceptJanuary 31, 2024 | marketbeat.comOpthea Limited (NASDAQ:OPT) Expected to Post FY2027 Earnings of $0.00 Per ShareOpthea Limited (NASDAQ:OPT - Free Report) - Leerink Partnrs issued their FY2027 EPS estimates for Opthea in a report released on Monday, January 29th. Leerink Partnrs analyst M. Goodman forecasts that the company will earn $0.00 per share for the year. The consensus estimate for Opthea's currentJanuary 12, 2024 | marketbeat.comShort Interest in Opthea Limited (NASDAQ:OPT) Rises By 70.4%Opthea Limited (NASDAQ:OPT - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 150,300 shares, a growth of 70.4% from the December 15th total of 88,200 shares. Based on an average daily trading volume, of 22,000 shares, the days-to-cover ratio is presently 6.8 days.December 27, 2023 | msn.comWhy Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?December 27, 2023 | msn.comOpthea to receive $35M commitment and additional $50M fundingDecember 27, 2023 | marketwatch.comOpthea Limited ADRs Rise 31% on Raised FundingDecember 27, 2023 | finance.yahoo.comOpthea to Receive US$35M Commitment and Additional US$50M FundingDecember 16, 2023 | msn.comOpthea Limited - ADR (OPT) Price Target Increased by 7.41% to 6.39December 1, 2023 | finance.yahoo.comOpthea to Present at the FLORetina 2023 CongressNovember 27, 2023 | msn.comOpthea Limited - ADR (OPT) Price Target Increased by 9.06% to 5.95November 9, 2023 | finance.yahoo.comOpthea to Present at the Jefferies 2023 London Healthcare ConferenceOctober 30, 2023 | finance.yahoo.comOpthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceOctober 27, 2023 | msn.comOpthea appoints U.S.-based leadership with Fred Guerard as CEOOctober 25, 2023 | finance.yahoo.comOpthea Limited (ASX:OPT) is definitely on the radar of institutional investors who own 38% of the companyOctober 25, 2023 | marketbeat.comTrading was temporarily halted for "OPT" at 06:10 PM with a stated reason of "News pending."September 13, 2023 | marketbeat.comOppenheimer Lowers Opthea (NASDAQ:OPT) Price Target to $16.00Oppenheimer cut their price objective on shares of Opthea from $31.00 to $16.00 in a report on Wednesday.September 7, 2023 | finance.yahoo.comOpthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 24, 2023 | marketbeat.comTrading was temporarily halted for "OPT" at 07:08 PM with a stated reason of "News pending."August 23, 2023 | afr.comCarlyle goes all in on biotech Opthea; MST launches $80m capital raiseAugust 3, 2023 | marketbeat.comVictory Capital Management Inc. Sells 50,429 Shares of Opthea Limited (NASDAQ:OPT)Victory Capital Management Inc. lowered its stake in Opthea Limited (NASDAQ:OPT - Free Report) by 4.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,127,566 shares of the company's stock after selling 50,429 sAugust 1, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on Opthea Limited Sponsored ADR (OPT)July 24, 2023 | finance.yahoo.comOpthea to Present at the 2023 Ophthalmology Innovation SummitJuly 10, 2023 | finance.yahoo.comOpthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorJune 11, 2023 | fool.comOpthea (NASDAQ: OPT) Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. OPT Media Mentions By Week OPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.710.55▲Average Medical News Sentiment OPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼31▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CGEN News ELEV News ZURA News ABOS News INMB News XFOR News KOD News IPHA News GNFT News ADVM News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
